TY  - CHAP
M1  - Book, Section
TI  - Acute Coronary Syndromes
A1  - Rogers, Kelly C.
A1  - Spinler, Sarah A.
A2  - Chisholm-Burns, Marie A.
A2  - Schwinghammer, Terry L.
A2  - Malone, Patrick M.
A2  - Kolesar, Jill M.
A2  - Bookstaver, P. Brandon
A2  - Lee, Kelly C.
PY  - 2022
T2  - Pharmacotherapy Principles & Practice, 6e
AB  - LEARNING  OBJECTIVESUpon  completion  of  the  chapter,  the  reader  will  be  able  to:Define  the  role  of  atherosclerotic  plaque,  platelets,  and  the  coagulation  system  in  an  acute  coronary  syndrome  (ACS).List  key  electrocardiographic  (ECG),  biomarker,  and  clinical  features  identifying  a  patient  with  non–ST-segment  elevation  (NSTE)-ACS  and  ST-segment  elevation  myocardial  infarction  (STEMI).Devise  an  initial,  early  pharmacotherapy  treatment  and  monitoring  plan  for  a  patient  presenting  with  either  NSTE-ACS  or  STEMI  given  patient-specific  data.Devise  an  antithrombotic  pharmacotherapy  treatment  and  monitoring  plan  for  a  patient  with  NSTE-ACS  or  STEMI  undergoing  percutaneous  coronary  intervention  (PCI)  given  patient-specific  data.Devise  an  antithrombotic  pharmacotherapy  treatment  and  monitoring  plan  for  a  patient  with  NSTE-ACS  or  STEMI  not  undergoing  PCI  given  patient-specific  data.Develop  a  pharmacotherapy  and  risk  factor  modification  treatment  plan  for  secondary  prevention  of  coronary  heart  disease  (CHD)  events  in  a  patient  following  NSTE-ACS  or  STEMI.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/18
UR  - apn.mhmedical.com/content.aspx?aid=1187007391
ER  -